Low Progesterone Receptor Expression Is Associated with Distant Metastasia in Estrogen Receptor Positive/HER2 Negative and Lymph Node Negative Breast Cancer

被引：0
|
作者：
Mendoza, Pia
Sonmez, Ceyda
Neely, Cameron
Zhang, Chao
Liu, Yuan
Li, Xiaoxian
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
228
引用
收藏
页码：59A / 59A
页数：1
相关论文
共 50 条
  • [21] The Survival Benefit of Endocrine Therapy in Low Estrogen Receptor Positive/HER2 Negative Invasive Breast Cancer
    Alhamar, Mohamed
    Alkamachi, Bassam
    Mehrotra, Harshita
    Ohan, Hovsep
    Ali, Haythem
    Gupta, Nilesh
    Hassan, Oudai
    Chitale, Dhananjay
    Schultz, Daniel
    Allo, Ghassan
    Alkhoory, Wamidh
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 74 - 76
  • [22] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Zheng, Hongjuan
    Ge, Chenyang
    Lin, Haiping
    Wu, Lunpo
    Wang, Qinghua
    Zhou, Shishi
    Tang, Wanfen
    Zhang, Xia
    Jin, Xiayun
    Xu, Xifeng
    Hong, Zhongwu
    Fu, Jianfei
    Du, Jinlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (07) : 1145 - 1153
  • [23] Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer
    Hongjuan Zheng
    Chenyang Ge
    Haiping Lin
    Lunpo Wu
    Qinghua Wang
    Shishi Zhou
    Wanfen Tang
    Xia Zhang
    Xiayun Jin
    Xifeng Xu
    Zhongwu Hong
    Jianfei Fu
    Jinlin Du
    International Journal of Clinical Oncology, 2022, 27 : 1145 - 1153
  • [24] The Survival Benefit of Endocrine Therapy in Low Estrogen Receptor Positive/HER2 Negative Invasive Breast Cancer
    Alhamar, Mohamed
    Alkamachi, Bassam
    Mehrotra, Harshita
    Ohan, Hovsep
    Ali, Haythem
    Gupta, Nilesh
    Hassan, Oudai
    Chitale, Dhananjay
    Schultz, Daniel
    Allo, Ghassan
    Alkhoory, Wamidh
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 74 - 76
  • [25] Reply letter to: Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer
    Liao, Guo-Shiou
    EJSO, 2018, 44 (04): : 540 - 540
  • [26] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    LABORATORY INVESTIGATION, 2006, 86 : 21A - 21A
  • [27] Histologic and immunophenotypic features of estrogen receptor, progesterone receptor, Her2/neu negative breast carcinomas
    Baruch, AC
    Sneige, N
    Cristofanilli, M
    Resetkova, E
    MODERN PATHOLOGY, 2006, 19 : 21A - 21A
  • [28] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Irfan Cicin
    Hakan Karagol
    Ufuk Usta
    Atakan Sezer
    Sernaz Uzunoglu
    Rusen Alas-Cosar
    Tarkan Yetisyigit
    Kazim Uygun
    Medical Oncology, 2009, 26 : 335 - 343
  • [29] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Cicin, Irfan
    Karagol, Hakan
    Usta, Ufuk
    Sezer, Atakan
    Uzunoglu, Sernaz
    Alas-Cosar, Rusen
    Yetisyigit, Tarkan
    Uygun, Kazim
    MEDICAL ONCOLOGY, 2009, 26 (03) : 335 - 343
  • [30] Breast cancer histological grade is associated with estrogen receptor (ER), progesterone receptor (PR), and HER2 expression
    Suzuki, M.
    Kimijima, I.
    Watanabe, K.
    EJC SUPPLEMENTS, 2008, 6 (07): : 102 - 102
12345